157 related articles for article (PubMed ID: 34333704)
1. Impact of Choosing Wisely Recommendations on Sentinel Lymph Node Biopsy and Postoperative Radiation Rates in Women Over Age 70 Years with Hormone-Positive Breast Cancer.
Thompson J; Le J; Hop A; Melnik M; Paulson J; Wright GP
Ann Surg Oncol; 2021 Oct; 28(10):5716-5722. PubMed ID: 34333704
[TBL] [Abstract][Full Text] [Related]
2. Use of sentinel lymph node biopsy in elderly patients with breast cancer - 10-year experience from a Swiss university hospital.
Heidinger M; Maggi N; Dutilh G; Mueller M; Eller RS; Loesch JM; Schwab FD; Kurzeder C; Weber WP
World J Surg Oncol; 2023 Jun; 21(1):176. PubMed ID: 37287038
[TBL] [Abstract][Full Text] [Related]
3. Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor-Positive Breast Cancer.
Carleton N; Zou J; Fang Y; Koscumb SE; Shah OS; Chen F; Beriwal S; Diego EJ; Brufsky AM; Oesterreich S; Shapiro SD; Ferris R; Emens LA; Tseng G; Marroquin OC; Lee AV; McAuliffe PF
JAMA Netw Open; 2021 Apr; 4(4):e216322. PubMed ID: 33856473
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node biopsy in women over 70: Evaluation of rates of axillary staging and impact on adjuvant therapy in elderly women.
Di Lena É; Antoun A; Hopkins B; Barone N; Do U; Meterissian S
Surgery; 2023 Mar; 173(3):603-611. PubMed ID: 36372577
[TBL] [Abstract][Full Text] [Related]
5. Is axillary lymph node dissection necessary after sentinel lymph node biopsy in patients with mastectomy and pathological N1 breast cancer?
Fu Y; Chung D; Cao MA; Apple S; Chang H
Ann Surg Oncol; 2014 Dec; 21(13):4109-23. PubMed ID: 25081336
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer hormone receptor negativity, triple-negative type, mastectomy and not receiving adjuvant radiotherapy were associated with axillary recurrence after sentinel lymph node biopsy.
Sekine C; Nakano S; Mibu A; Otsuka M; Oinuma T; Takeyama H
Asian J Surg; 2020 Jan; 43(1):148-153. PubMed ID: 31153730
[TBL] [Abstract][Full Text] [Related]
7. Nodal Recurrence in Patients With Node-Positive Breast Cancer Treated With Sentinel Node Biopsy Alone After Neoadjuvant Chemotherapy-A Rare Event.
Barrio AV; Montagna G; Mamtani A; Sevilimedu V; Edelweiss M; Capko D; Cody HS; El-Tamer M; Gemignani ML; Heerdt A; Kirstein L; Moo TA; Pilewskie M; Plitas G; Sacchini V; Sclafani L; Tadros A; Van Zee KJ; Morrow M
JAMA Oncol; 2021 Dec; 7(12):1851-1855. PubMed ID: 34617979
[TBL] [Abstract][Full Text] [Related]
8. The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era.
Mann JM; Wu X; Christos P; Nagar H
Clin Breast Cancer; 2018 Aug; 18(4):e477-e493. PubMed ID: 29031423
[TBL] [Abstract][Full Text] [Related]
9. Oncologic Safety of Sentinel Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy for Breast Cancer.
Wong SM; Basik M; Florianova L; Margolese R; Dumitra S; Muanza T; Carbonneau A; Ferrario C; Boileau JF
Ann Surg Oncol; 2021 May; 28(5):2621-2629. PubMed ID: 33095362
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of Stage I and II Breast Cancer with Nodal Micrometastases Treated with Mastectomy without Axillary Therapy.
Lim SZ; Kusumawidjaja G; Mohd Ishak HM; Tan BKT; Tan SY; Hamzah JL; Madhukumar P; Yong WS; Wong CY; Sim Y; Lim GH; Lim SH; Tan SM; Wong FY; Tan VKM
Breast Cancer Res Treat; 2021 Oct; 189(3):837-843. PubMed ID: 34342766
[TBL] [Abstract][Full Text] [Related]
11. Sentinel Node Biopsy Should Not be Routine in Older Patients with ER-Positive HER2-Negative Breast Cancer Who Are Willing and Able to Take Hormone Therapy.
McKevitt E; Cheifetz R; DeVries K; Laws A; Warburton R; Gondara L; Lohrisch C; Nichol A
Ann Surg Oncol; 2021 Oct; 28(11):5950-5957. PubMed ID: 33817760
[TBL] [Abstract][Full Text] [Related]
12. Luminal A Versus B After Choosing Wisely: Does Lymph Node Surgery Affect Oncologic Outcomes?
Ong C; Blue CM; Khan J; Deng X; Bandyopadhyay D; Louie RJ; McGuire KP
Ann Surg Oncol; 2024 Jan; 31(1):335-343. PubMed ID: 37831277
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of clinically node-negative breast cancer without axillary dissection: can preserved axilla be safely treated with radiation after a positive sentinel node biopsy?
Sanuki N; Takeda A; Amemiya A; Ofuchi T; Ono M; Ogata H; Yamagami R; Hatayama J; Eriguchi T; Kunieda E
Clin Breast Cancer; 2013 Feb; 13(1):69-76. PubMed ID: 23062706
[TBL] [Abstract][Full Text] [Related]
14. Impact of Axillary Dissection Among Patients With Sentinel Node-Positive Breast Cancer Undergoing Mastectomy.
Sun J; Mathias BJ; Laronga C; Sun W; Zhou JM; Fulp WJ; Kiluk JV; Lee MC
J Natl Compr Canc Netw; 2021 Jan; 19(1):40-47. PubMed ID: 33406495
[TBL] [Abstract][Full Text] [Related]
15. Pre-mastectomy sentinel lymph node biopsy: a strategy to enhance outcomes in immediate breast reconstruction.
Teven C; Agarwal S; Jaskowiak N; Park JE; Chhablani A; Seitz IA; Song DH
Breast J; 2013; 19(5):496-503. PubMed ID: 23773780
[TBL] [Abstract][Full Text] [Related]
16. Decreasing the Use of Sentinel Lymph Node Surgery in Women Older than 70 Years with Hormone Receptor-Positive Breast Cancer and the Impact on Adjuvant Radiation and Hormonal Therapy.
Tonneson JE; Hoskin TL; Durgan DM; Corbin KS; Goetz MP; Boughey JC
Ann Surg Oncol; 2021 Dec; 28(13):8766-8774. PubMed ID: 34258721
[TBL] [Abstract][Full Text] [Related]
17. Application of the ACOSOG Z0011 criteria to Chinese patients with breast cancer: a prospective study.
Peng Y; Liu M; Li X; Tong F; Cao Y; Liu P; Zhou B; Liu H; Cheng L; Guo J; Xie F; Yang H; Wang S; Wang C; Chen Y; Wang S
World J Surg Oncol; 2021 Apr; 19(1):128. PubMed ID: 33879180
[TBL] [Abstract][Full Text] [Related]
18. Factors Predictive of Sentinel Lymph Node Involvement in Primary Breast Cancer.
Malter W; Hellmich M; Badian M; Kirn V; Mallmann P; Krämer S
Anticancer Res; 2018 Jun; 38(6):3657-3662. PubMed ID: 29848724
[TBL] [Abstract][Full Text] [Related]
19. Effect of axillary lymph node dissection after sentinel lymph node biopsy on overall survival in patients with T1 or T2 node-positive breast cancer: report from the Korean Breast Cancer Society.
Park HS; Chae BJ; Song BJ; Jung SS; Han W; Nam SJ; Youn HJ; Ko BK; Kim DW;
Ann Surg Oncol; 2014 Apr; 21(4):1231-6. PubMed ID: 24318094
[TBL] [Abstract][Full Text] [Related]
20. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
